International Assets Investment Management LLC Invests $4.70 Million in Sanofi (NASDAQ:SNY)

International Assets Investment Management LLC bought a new position in shares of Sanofi (NASDAQ:SNY) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 94,586 shares of the company’s stock, valued at approximately $4,704,000.

Several other hedge funds have also added to or reduced their stakes in SNY. Bleakley Financial Group LLC grew its position in shares of Sanofi by 27.8% during the 4th quarter. Bleakley Financial Group LLC now owns 96,424 shares of the company’s stock worth $4,795,000 after purchasing an additional 20,984 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in Sanofi by 5.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 46,350 shares of the company’s stock worth $2,305,000 after acquiring an additional 2,464 shares during the period. Prime Capital Investment Advisors LLC acquired a new position in Sanofi in the 4th quarter valued at $201,000. Sowell Financial Services LLC lifted its position in shares of Sanofi by 57.8% during the 4th quarter. Sowell Financial Services LLC now owns 21,144 shares of the company’s stock valued at $1,051,000 after acquiring an additional 7,748 shares during the period. Finally, Augustine Asset Management Inc. grew its holdings in shares of Sanofi by 166.5% during the 4th quarter. Augustine Asset Management Inc. now owns 81,945 shares of the company’s stock worth $4,075,000 after purchasing an additional 51,198 shares in the last quarter. 10.04% of the stock is owned by institutional investors and hedge funds.

Sanofi Stock Up 1.1 %

SNY stock opened at $50.10 on Thursday. The stock has a market capitalization of $126.73 billion, a P/E ratio of 25.18, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. The firm has a 50-day moving average price of $47.95 and a 200-day moving average price of $48.12. Sanofi has a 12 month low of $42.63 and a 12 month high of $55.72.

Sanofi Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, June 6th. Shareholders of record on Friday, May 10th will be paid a dividend of $1.478 per share. This represents a dividend yield of 2.98%. The ex-dividend date of this dividend is Thursday, May 9th. This is a boost from Sanofi’s previous annual dividend of $1.38. Sanofi’s payout ratio is presently 69.35%.

Analysts Set New Price Targets

Several research firms recently weighed in on SNY. Morgan Stanley started coverage on shares of Sanofi in a research report on Tuesday, January 23rd. They set an “equal weight” rating and a $55.00 price objective for the company. StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, TheStreet downgraded shares of Sanofi from a “b” rating to a “c” rating in a research report on Friday, February 9th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $55.00.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.